Clinical Trials Browser

Active not recruiting × Interventional × tomivosertib × Clear all

NCT05744739 2025-10-21

Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04622007 2024-04-30

KICKSTART

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung